Picture a 28-year-old woman walking into a consultation to manage her hormonal health.

The consultation goes well. The doctor listens, orders the right tests, and explains the medical protocol for the next 12 weeks. It covers a change in diet, a supplement, a few lifestyle adjustments, and a sleep target. She leaves with a printed protocol and a follow-up booked in six weeks, the midpoint check of the 12-week protocol.

With a plan in hand and hope, she walks back into her daily routine, and life catches up.

Around week three, she notices a lapse in adherence and lets it go, thinking she can come back on track. She hasn't given up. She is busy. By week five, she is only about 50% compliant with the protocol, a figure that, for illustration, mirrors the widespread problem of non-adherence [1]. No one, including her, would know that number.

At the second consultation in week six, she sits across from the doctor and tries to summarize the last six weeks in about two minutes. She remembers the last few days clearly and the rest only vaguely. The doctor works with what she can recall, and neither of them can see what actually happened in between.

This is the Blind Spot.

This is not a failure of medicine: the diagnosis was sound and the protocol was thoughtful. Health isn't lived in consultations. It is lived in the weeks between them: in sleep, stress, meals, travel, symptoms and small decisions made daily. These are the weeks where a protocol either takes hold or quietly falls apart.

What actually occurs between consultations

There are three invisible things at play in the six weeks leading to consultation 2.

1. The patient's own experience is never written down. A new soreness is noticed but never recorded, so no one can tell whether it came from a medication, a supplement or just a bad night's sleep. Sleep quality drops slowly over a few weeks. Her symptoms shift in small ways: a better morning, a worse afternoon, a day when she feels almost normal and doesn't know why. By week six, the experiences have blurred into "mostly fine, I think".

2. Everything a measurement could have captured goes unmeasured. Her body produced a continuous record over those weeks: heart rhythm, sleep patterns, activity, recovery. Technology that can capture these signals already exists, from consumer wearables to clinical-grade ambulatory ECG monitors such as Holter devices. At-home tests using urine or saliva are emerging too, and they will bring more of the lab into daily life. None of it reaches the consultation room.

3. The behavioral record is missing. The doctor knows what was prescribed, but nobody knows what was actually done: which days the supplement was taken, how often the sleep target was met, which meals followed the plan and which didn't.

The compound problem

Each gap alone would limit the second consultation. Together they compound. The subjective record is unwritten, the objective record is unmeasured, the behavioral record is unknown, and the doctor and patient meet in week six with no shared picture of weeks one to five. The second consultation inherits none of what happened after the first, and the protocol is adjusted on recall and a point-in-time assessment.

The stakes for patient, clinician and system

The Blind Spot has a cost, paid by three parties: the patient, the clinician, and the healthcare system.

1. For the patient

Look at week six. The protocol is adjusted on a partial picture. If the supplement isn't working, no one can tell whether it was the wrong supplement or whether it was taken only half the time. If sleep slipped, no one knows whether it was the week of a work deadline rather than the protocol itself. A recovery planned for twelve weeks could stretch to sixteen, or twenty. The longer it takes, the higher the cost of care.

Then there is confidence. Without adherence data, the small wins go unseen and the lapses can feel bigger than they are. Confidence goes first, then engagement. Some patients may never make it to the second consultation. They don't decide to quit; they simply stop. And every month a condition is poorly managed tends to show up later as more tests, more appointments and more treatment. Non-adherence alone is estimated to increase healthcare costs for the patient, compounded by loss of productivity, absenteeism and presenteeism.

Research on Indian women with polycystic ovarian syndrome found that non-adherence to treatment regimens was a significant barrier to effective care. Contributing factors included lack of understanding of the treatment plan, side effects and lifestyle challenges [2].

2. For the clinician

The doctor designed a thoughtful protocol and then lost sight of it for six weeks. A problem that appeared in week two, such as a supplement that didn't agree or a sleep pattern that collapsed, could have been corrected with a short message. Instead it could surface in week six. The clinician makes decisions from a two-minute recollection and a single set of results: a snapshot of a story that played out over 42 days. Good clinical judgment depends on good information, and the Blind Spot withholds the information that matters most, which is how the protocol behaved in real life.

3. For the healthcare system

Multiply this story across every patient in every program. A program can be well designed and still appear to fail, because no one can separate a protocol that doesn't work from a protocol that wasn't followed. Outcomes data reflects what was recorded at consultations, not what happened between them. Programs are judged, funded and redesigned on incomplete evidence. The system cannot learn from what it cannot see.

The four domains the Blind Spot touches

The Blind Spot is not a single gap. It runs through every part of a person's life between consultations, and touches four areas of it: Body, Mind, Heart and Environment.

a.Body. The Body is where care already looks most closely: physical symptoms, mobility, sleep, and the response to a medication or supplement. It is also the domain where measurement is most mature, through wearables, ambulatory monitors and lab tests. Yet between consultations, even the Body goes largely unrecorded. A new soreness, a dip in energy, a change in sleep: each is a signal the body produces every day, and one that the consultation rarely sees.

b.Mind. The Mind is the cognitive load of everyday life: focus, mental fatigue, and how stress is processed. A protocol competes for attention with work, family and everything else. When the mind is overloaded, the protocol is often the first thing to slip. Not because it matters less, but because it asks for one more decision in a day already full of them.

c.Heart. The Heart is motivation, emotional state and a person's relationship with their own care. It is the reason someone keeps going in week four, or doesn't. The hope carried out of the first consultation can fade into doubt when progress is invisible. How a person feels about their care shapes whether they stay with it.

d.Environment. The Environment is the context everything else happens in: home, daily routine, work schedules, travel and the people around them. It is the invisible shaper of adherence. A protocol designed for a calm, predictable week meets a week with a deadline, a trip or a family event. Support at home can carry a person through a hard stretch; its absence can quietly undo the best plan.

These domains do not act alone. Health biomarkers sit in the Body, but they are moved by the other three. Stress in the Mind disrupts sleep and hormones. Fading motivation in the Heart lowers adherence. A chaotic routine in the Environment breaks the habits a protocol depends on. This is the premise of Integrative Health and Wellbeing: to manage health biomarkers, care must also work on the Mind, Heart and Environment factors that drive them.

The consultation sees mostly the Body, at a single point in time. The Blind Spot holds all four, every day. A real solution has to cover all four addresses, continuously, and connect them. This is the BMHE framework: Body, Mind, Heart, Environment. It is the framework that OHUE-SIRA uses to structure the Blind Spot.

OHUE-SIRA's view on the next generation of healthcare

The medical fraternity has long recognized the Blind Spot, and several approaches already reach into the weeks between consultations. There are extended care teams of nutritionists, integrative health and wellbeing coaches, physiotherapists and nurses. There are adherence guides and checklists, and content libraries of articles, videos and courses.

Technology is also catching up. At-home tests are bringing parts of the lab into daily life: finger-prick blood kits can track markers such as HbA1c, lipids, thyroid function and hormones, saliva tests can measure cortisol, and urine tests read with a smartphone camera are beginning to support kidney screening. Wearables and sensors now carry regulatory clearances once reserved for medical devices, and smartwatches can record a single-lead ECG and flag irregular heart rhythms. Together, these devices produce digital biomarkers that turn a stream of data into health signals: heart rate variability, resting heart rate, sleep stages, skin temperature, activity and gait. Measured every day, they reach beyond the Body. Heart rate variability and sleep reflect stress in the Mind, and activity and routine patterns trace the Environment.

Three things define the next generation of care:

• A longitudinal health record. Every week adds to a record that travels with the individual across programs, providers and time. Each new consultation starts from what has already been learned, not from a blank page.

• Coverage of all four addresses. Built on the BMHE framework, a longitudinal approach looks across Body, Mind, Heart and Environment, and at how they connect, not only at the biomarkers.

• Bridging the consultations. Consultation 1, the Blind Spot and Consultation 2 become one continuous story. When the doctor and patient meet in week six, they share a structured picture of weeks one to five instead of a two-minute recollection.

References

[1] Pruitt SD, Khan R, Chaiyakunapruk N, et al. The silent epidemic of non-adherence – insights from the 2024 a:care congress. BMC Proc. 2025;19(Suppl 10):13. https://doi.org/10.1186/s12919-025-00326-4

[2] Vijayan SM, Kalaivani H, Mitra S, John J, Anila A, Damini, Boban L, Chowdhury P, Gayen S. Barriers to treatment regimen adherence in Indian women with polycystic ovarian syndrome. J Family Med Prim Care. 2022;11(7):3687-3692. doi: 10.4103/jfmpc.jfmpc_2360_21. PMID: 36387674.